Zoetis (ZTS) Reports Flat Q2 2026 Revenue at $2.5 Billion

Zoetis Inc. (NYSE: ZTS) reported fiscal Q2 2026 revenue of $2.5 billion, reflecting flat performance and a 1% decline on an organic operational basis. The decline was primarily driven by pressures within the U.S. companion-animal market, which saw a 7% revenue drop and 11% decline in companion-animal product sales. Conversely, livestock revenue grew 12%, bolstered by a 23% increase in the U.S. Livestock segment. The company is looking to restore growth through a pipeline of over 12 potential blockbuster candidates and the recent acquisition of VitalRADS for expanded diagnostics. This matters for investors as it highlights Zoetis's resilience and potential for future growth despite current market challenges.